Håll dig uppdaterad
Anmäl dig för att få våra digitala utskick.
Lipoprotein(a) in the Nordics – national perspectives, shared challenges
Take the opportunity to deepen your knowledge of lipoprotein(a) through unique insights from across the Nordic region.
Date and time: Wednesday, May 6, 16:00 – 17:00
Location: Webinar, Microsoft Teams
Lipoprotein(a), Lp(a), is an inherited and independent risk factor for cardiovascular disease¹ — but what is the current level of awareness, testing, and management of Lp(a) across the Nordic countries? Do clinical practices differ? And what can we learn from one another?
In this Nordic webinar, leading experts from Denmark, Finland, Norway, and Sweden come together to share national experiences and highlight different aspects of Lp(a) — from screening and diagnostics to clinical management and the patient perspective.
Each country contributes with a concrete example that sheds light on a specific part of the Lp(a) landscape. Together, these perspectives provide a broad and nuanced view of where we are today — and where we are heading.
PROGRAM
Moderator: Nikolaj Krarup, Department physician, PhD, Viborg Regional Hospital
16:00 Introduction
Nikolaj Krarup, Department physician, PhD, Viborg Regional Hospital
16:05 Beyond the individual - cascade testing as a strategy to uncover familial Lp(a) risk
Ass. Professor Jonas Brinck, Senior Consultant, Karolinska University Hospital
16:15 Lp(a) Testing in Primary Care in Norway: When should specialists be involved?
Professor Kjetil Retterstøl, MD, PhD, University of Oslo and the Lipid Clinic at Oslo University Hospital, Norway
16:25 Implementing Lp(a) testing in the cardiac rehabilitation - a raison d'être
Nikolaj Krarup, Department physician, PhD, Viborg Regional Hospital
16:35 Unravelling complexity – challenging ASCVD patients with high Lp(a) in the lipid clinic
Professor Johanna Kuusisto, Kuopio University Hospital and University of Eastern Finland
16:45 Panel Discussion
Nikolaj Krarup, Department physician, PhD, Viborg Regional Hospital
Warm welcome,
Novartis
This educational event is organized by Novartis Denmark, Novartis Finland, Novartis Norway and Novartis Sweden and it is intended for physicians and nurses. Novartis covers the cost for speaker fees and streaming of the event. Swedish participants needs approval from their principal in order to participate.
References
1. Mach F, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2025;00:1–20. https://doi.org/10.1093/eurheartj/ehaf190
Få svar på dina frågor
